Chapter 5
Catheter Closure of Patent Foramen Ovale
Nina Wunderlich MD,
Katharina Lehn,
Neil Wilson MB BS, DCH, FRCP, FRCP(CH),
Horst Sievert MD, FESC, FACC,
Nina Wunderlich MD
Department of Cardiology, CardioVascular Center Frankfurt, Frankfurt, Germany
Search for more papers by this authorKatharina Lehn
Cardiovascular Center Frankfurt, Frankfurt, Germany
Search for more papers by this authorNeil Wilson MB BS, DCH, FRCP, FRCP(CH)
Consultant Paediatric Cardiologist Director
Paediatric Cardiac Catheter Laboratory, Department of Paediatrics, John Radcliffe Hospital, University of Oxford, Oxford, UK
Search for more papers by this authorHorst Sievert MD, FESC, FACC
Professor of Medicine Head
Department of Cardiology, CardioVascular Center Frankfurt, Frankfurt, Germany
Search for more papers by this authorNina Wunderlich MD,
Katharina Lehn,
Neil Wilson MB BS, DCH, FRCP, FRCP(CH),
Horst Sievert MD, FESC, FACC,
Nina Wunderlich MD
Department of Cardiology, CardioVascular Center Frankfurt, Frankfurt, Germany
Search for more papers by this authorKatharina Lehn
Cardiovascular Center Frankfurt, Frankfurt, Germany
Search for more papers by this authorNeil Wilson MB BS, DCH, FRCP, FRCP(CH)
Consultant Paediatric Cardiologist Director
Paediatric Cardiac Catheter Laboratory, Department of Paediatrics, John Radcliffe Hospital, University of Oxford, Oxford, UK
Search for more papers by this authorHorst Sievert MD, FESC, FACC
Professor of Medicine Head
Department of Cardiology, CardioVascular Center Frankfurt, Frankfurt, Germany
Search for more papers by this authorBook Editor(s):Jürgen Haase MD, PhD, FESC, FACC,
Hans-Joachim Schäfers MD, PhD,
Horst Sievert MD, FESC, FACC,
Ron Waksman MD, FACC,
Jürgen Haase MD, PhD, FESC, FACC
Professor of Medicine Consultant Cardiologist
Kardiocentrum Frankfurt, Klinik Rotes Kreuz, Frankfurt/Main, Germany
Search for more papers by this authorHans-Joachim Schäfers MD, PhD
Professor of Surgery Chair
Department of Thoracic and Cardiovascular Surgery, University Hospital Saarland, Homburg/Saar, Germany
Search for more papers by this authorHorst Sievert MD, FESC, FACC
Professor of Medicine Head
Department of Cardiology, CardioVascular Center Frankfurt, Frankfurt, Germany
Search for more papers by this authorRon Waksman MD, FACC
Professor of Medicine Associate Director Director
Division of Cardiology, Washington, DC, USA
Experimental Cardiology, Washington Hospital Center, Washington, DC, USA
Search for more papers by this authorFirst published: 10 May 2010
Summary
This chapter contains sections titled:
-
Historical background
-
Morphology and pathophysiology of patent foramen ovale
-
Indications for patent foramen ovale closure
-
Technical aspects
-
Summary
-
References
References
- Bridges ND, Hellenbrand W, Latson L, Filiano J, Newburger JW, & Lock JE (1992) Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation 86: 1902–1908.
- Sievert H, Trepels T, Zadan E, et al. (2001) Catheter closure of PFO for prevention of recurrent embolic stroke and TIA: acute results and follow-up in 400 patients. Am J Cardiol 88(Suppl. 1): 118–120.
- Sievert H, Ostermayer S, Billinger K, et al. (2002) Transcatheter closure of PFO for prevention of paradoxical embolism and recurrent embolic stroke with the CardioSeal STARFlex occluder. Am J Cardiol 90(Suppl. 1): H37–H39.
- Sommer RJ, Kramer PH, Sorensen SG, et al. (2002) Closure of PFO with CardioSeal Septal Occluder: highly effective intervention. Am J Cardiol 90(Suppl. 1): H37.
- Hagen PT, Scholz DG, & Edwards WD (1984) Incidence and size of patent foramen ovale during the first 10 decades of life: An autopsy study of 967 normal hearts. Mayo Clin Proc 59: 17–20.
- Mas JL (1994) Patent foramen ovale, atrial septal aneurysm and ischemic stroke in young adults. Eur Heart J 15: 446–449.
- Berthet K, Lavergne T, Cohen A, et al. (2000) Significant association of the atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause. Stroke 31: 398–403.
- Lechat P, Mas J, & Laseault G (1988) Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 318: 1148–1152.
- Webster M, Chancellor A, & Smith H (1988) Patent foramen ovale in young stroke patients. Lancet 2: 11–12.
- Steiner M, Di Tuillio MR, Rundek T, et al. (1998) Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke. Stroke 29: 944–948.
- Harvey JR, Teague SM, Anderson JL, Voyles WF, & Thadani U (1986) Clinically silent atrial septal defects with evidence of cerebral embolizaton. Ann Intern Med 105: 695–697.
- Handke M, Harloff A, Olschewski M, et al. (2007) Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med 357: 2262–2268.
- Bogousslavsky J, Garazi S, Jeanrenaud X, Aebischer N, & Van Melle G (1996) Stroke recurrence in patients with patent foramen ovale. The Lausanne study. Lausanne stroke with paradoxical embolism study group. Neurology 46: 1301–1305.
- Mas JL & Zuber M (1995) Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. French study group on patent foramen ovale and atrial septal aneurysm. Am Heart J 130: 1083–1088.
- De Castro S, Cartoni D, Fiorelli M, et al. (2000) Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke 31: 2407–2413.
- Nedeltchev K, Arnold M, Wahl A, et al. (2002) Outcome of patients with cryptogenic stroke and patent foramen ovale. J Neurol Neurosurg Psychatry 72: 347–350.
- Homma S, Sacco RL, Di Tullio MR, Sciacca RR, & Mohr J; PFO in Cryptogenic Stroke Study (PICSS) Investigators. (2002) Effect of medical treatment in stroke patients with patent foramen ovale in Cryptogenic Stroke Study. Circulation 5: 2625–2631.
- Stone DA, Godard J, Coretti MC, et al. (1996) Patent foramen ovale: association between the degree of shunt by contrast transesophageal echocardiography and the risk of future ischemic neurological events. Am Heart J 131: 158–161.
- Overell JR, Bone I, & Lees KR (2000) Interatrial septal abnormalities and stroke: a meta-analysis of case–control studies. Neurology 55: 1172–1179.
- Mas JL, Arquizan C, Lamy C, et al.; for the patent foramen ovale and atrial septal aneurysm study group. (2001) Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 345: 1740–1746.
- Schuchlenz HW, Weihs W, Horner S, & Quehenberger F (2000) The association between the diameter of a patent foramen ovale and the risk of embolic cerebrovascular events. Am J Med 109: 456–462.
- Meissner I, Khandheria BK, Heit JA, et al. (2006) Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study. J Am Coll Cardiol 47: 440–445.
- Di Tullio MR, Sacco RL, Sciacca RR, Jin Z, & Homma S (2007) Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol 49: 797–802.
- Anzola GP, Magoni M, Guindani M, Rozzini L, & Dalla Volta G (1999) Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology 52: 1622–1625.
- Pitt BR, Hammond GL, & Gillis CN (1982) Comparison of pulmonary and extrapulmonary extraction of biogenic amines. J Appl Physiol 52: 1330–1332.
- Kerut EK, Norfleet WT, Plotnick GD, & Giles TD (2001) Patent foramen ovale: a review of associated conditions and the impact of physiological size. J Am Coll Cardiol 38: 613–623.
- Germonpre P, Hashi F, Dendale P, et al. (2005) Evidence for increasing patency of the foramen ovale in divers. Am J Cardiol 95: 912–915.
- Chen GP, Goldberg SL, & Gill EA Jr. (2005) Patent foramen ovale and platypnea-orthodeoxia syndrome. Cardiol Clin 23: 85–89.
- Sacco RL, Adams R, Albers G, et al. (2006) Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heat Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline. Circulation 113: 409–449.
- Messe SR, Siverman IE, Kizer JR, et al. (2004) Practice parameter: recurrent stroke with patent foramen ovale and atrial aneurysm: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 62: 1042–1050.
- Schwerzmann M, Nedeltcher K, Lagger F, et al. (2005) Prevalence and size of directly detected patent foramen ovale in migraine with aura. Neurology 65: 1415–1418.
- Reisman M, Christofferson RD, Jesurum J, et al. (2005) Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol 45: 493–495.
- Alameddine F & Block PC (2004) Transcatheter patent foramen ovale closure for secondary prevention of paradoxical embolic events: acute results from the FORECAST registry. Catheter Cardiovasc Interv 62: 512–516.
- Kiblawi FM, Sommer RJ, & Levchuck SG (2006) Transcatheter closure of patent foramen ovale in older adults. Catheter Cardiovasc Interv 68: 136–143.
-
Dowson A, Wilmshurst P, Muir KW, Mullen M, & Nightingale S (2006) A prospective, multicenter, randomized, double blind, placebo-controlled trial to evaluate the efficacy of patent foramen ovale closure with the STARFlex septal repair implant to prevent refractory migraine headaches: the MIST Trial. Neurology 67: 185.
10.1212/01.wnl.0000234883.34790.8d Google Scholar
- Jux C, Bertram H, Wohlsein P, Bruegmann M, & Paul T (2006) Interventional atrial septal defect closure using a totally bioresorbable occluder matrix: development and preclinical evaluation of the BioSTAR device. J Am Coll Cardiol 48: 161–169.
- Jux C, Wohlsein P, Bruegmann M, Zutz M, Franzbach B, & Bertram H (2003) A new biological matrix for septal occlusion. J Interv Cardiol 16: 149–152.
- Mullen MJ, Hildick-Smith D, De Giovanni JV, et al. (2006) BioSTAR Evaluation Study (BEST): a prospective, multicenter, phase I clinical trial to evaluate the feasibility, efficacy, and safety of the BioSTAR bioabsorbable septal repair implant for the closure of atrial-level shunts. Circulation 114: 1962–1967.
-
Masura J, Gavora P, Formanek A, & Hijazi ZM (1997) Trans-catheter closure of secundum atrial defects using the new self-centering Amplatzer septal occluder: initial human experiences. Catheter Cardiovasc Diagn 42: 388–393.
10.1002/(SICI)1097-0304(199712)42:4<388::AID-CCD7>3.0.CO;2-7 CAS PubMed Web of Science® Google Scholar
- Berger F, Ewert P, Bjornstad PG, et al. (1999) Transcatheter closure as standard treatment for most interatrial defects: experience in 200 patients treated with the Amplatzer septal occluder. Cardiol Young 9: 468–473.
-
Han YM, Gu X, Titus JL, et al. (1999) New self-expanding patent foramen ovale occluder device. Catheter Cardiovasc Interv 47: 370–376.
10.1002/(SICI)1522-726X(199907)47:3<370::AID-CCD27>3.0.CO;2-9 CAS PubMed Web of Science® Google Scholar
-
Waight DJ, Cao QL, & Hijazi ZM (2000) Closure of patent foramen ovale in patients with orthodeoxia-platypnea using the amplatzer devices. Catheter Cardiovasc Interv 50: 195–198.
10.1002/(SICI)1522-726X(200006)50:2<195::AID-CCD11>3.0.CO;2-F CAS PubMed Web of Science® Google Scholar
- Wahl A, Meier B, Haxel B, et al. (2001) Prognosis after percutaneous closure of patent foramen ovale for paradoxical embolism. Neurology 57: 1330–1332.
- Sievert H, Horvath K, Zadan E, et al. (2001) Patent foramen ovale closure in patients with transient ischemic attack/stroke. J Interv Cardiol 14: 261–266.
- Braun M, Gliech V, Boscheri A, et al. (2004) Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Periprocedural safety and mid-term follow-up results of three different device occluder systems. Eur Heart J 25: 424–430.
- Hong TE, Thaler D, Brorson J, Heitschmidt M, & Hijazi ZM; Amplatzer PFO Investigators. (2000) Transcatheter closure of patent foramen ovale associated with paradoxical embolism using the Amplatzer PFO occluder: initial and intermediate-term results of the U.S. multicenter clinical trial. Catheter Cardiovasc Interv 60: 524–528.
- Khositseth A, Cabalka AK, Sweeney JP, et al. (2004) Transcatheter Amplatzer device closure of atrial septal defects and patent foramen ovale in patients with presumed paradoxical embolism. Mayo Clin Proc 79: 35–41.
- Chatterjee T, Petzsch M, Ince H, et al. (2005) Interventional closure with Amplatzer PFO occluder of patent foramen ovale in patients with paradoxical cerebral embolism. J Interv Cardiol 18: 173–179.
- Thanopoulos BV, Dardas PD, Karanasios E, & Mezilis N (2006) Transcatheter closure versus medical therapy of patent foramen ovale and cryptogenic stroke. Catheter Cardiovasc Interv 86: 741–746.
- Billinger K, Ostermeyer S, Carminati M, et al. (2006) HELEX Septal Occluder for transcatheter closure of patent foramen ovale: multicenter experience. Euro Interv 1: 465–471.
- Buschek F, Sievert H, Kleber F, et al. (2006) Patent foramen ovale closure using the Premere device: the results of the CLOSEUP trial. J Interv Cardiol 19: 328–333.
-
Spies C, Doshi R, Timmermanns I, & Schrader E (2006) Closure of patent foramen ovale in patients with cryptogenic thromboembolic events using the Cardia PFO occluder. Eur Heart J 37: 365–371.
10.1093/eurheartj/ehi617 Google Scholar
- Spies C, Timmermanns I, Reissmann U, van Essen J, & Schräder R (2008) Patent foramen ovale closure with the Intrasept occluder: Complete 6–56 months follow-up of 247 patients after presumed paradoxical embolism. Catheter Cardiovasc Interv 71: 390–395.
- Ewert P, Söderberg B, Dähnert I, et al. (2008) ASD and PFO closure with the Solysafe septal occluder—results of a prospective multicenter pilot study. Catheter Cardiovasc Interv 71: 398–402.
- Krizanic F, Sievert H, Pfeiffer D, et al. (2008) Clinical evaluation of a novel occluder device (Occlutech) for percutaneous trans-catheter closure of patent foramen ovale (PFO). Clin Res Cardiol 97: 872–877.
- Reiffenstein I, Majunke N, Wunderlich N, et al. (2008) Percutaneous closure of patent foramen ovale with a novel FlatStent. Expert Rev Med Devices 5: 419–425.
- Sievert H, Fischer E, Heinisch C, Majunke N, Roemer A, & Wunderlich N (2007) Transcatheter closure of patent foramen ovale without an implant: initial clinical experience. Circulation 116: 1701–1706.
- Krumsdorf U, Ostermayer S, Billinger K, et al. (2004) Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1000 consecutive patients. J Am Col Cardiol 43: 302–309.
- Trepels T, Zeplin H, Sievert H, et al. (2003) Cardiac perforation following transcatheter PFO closure. Catheter Interven 58: 111–113.
- Palma G, Rosapepe F, Vicchio M, Russolillo V, Cioffi S, & Vosa C (2007) Late perforation of right atrium and aortic root after percutaneous closure of patent foramen ovale. J Thorac Cardiovasc Surg 134: 1054–1055.
